Filing Details

Accession Number:
0001849521-24-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-30 20:31:35
Reporting Period:
2023-01-26
Accepted Time:
2024-01-30 20:31:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Aspira Women's Health Inc. AWH In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1849521 Nicole Sandford C/O Aspira Women'S Health Inc
12117 Bee Caves Rd Bldg 3-100
Austin TX 78738
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-26 2,400 $0.00 61,103 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.001 Warrant (Right to Buy) Acquisiton 2024-01-26 2,400 $0.00 2,400 $4.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,400 2024-07-26 2029-07-26 No 4 P Direct
Footnotes
  1. Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $4.255.